Tag: CPAP Mask
F&P Healthcare raises guidance
March 25, 2024HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has raised its guidance for the financial year ending March 31, 2024, to $1.73 billion in operating revenue and $260 million to $265 million in net profit after tax. The guidance is slightly up from $1.7 billion in operating revenue and $250 million to $260 million in net profit after tax. “In OSA masks, we have continued to see strong performance from our Evora Full mask,” said Lewis Gradon, managing director and CEO. “We...
F&P reduces guesswork in mask sizing
January 30, 2024HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has launched a significant upgrade to its F&P myMask App, offering mask selection and sizing in addition to the existing step-by-step education and support video content. Health care professionals can now “select, size and assist” while with a patient or do so remotely via a text invitation to a patient’s smartphone, reducing the time and guesswork associated with traditional sizing, the company says. “This addition...
ResMed on mask recall, big tech and demand-gen
January 26, 2024Liz Beaulieu, Editor
SAN DIEGO – ResMed CEO Mick Farrell said a recall of its CPAP masks with magnets did not impact the company’s sales for the second quarter ended Dec. 31, 2023.
ResMed in November issued an urgent field safety notice to patients detailing possible interference with its AirFit and AirTouch masks and certain medical devices; the company in December then announced a voluntary global field action to update its guides. The U.S. Food and Drug Administration in January classified...
F&P reports 28% increase in mask revenue
December 1, 2023Liz Beaulieu, Editor
AUCKLAND, New Zealand – Fisher & Paykel Healthcare continues to post solid results for its Homecare Product Group, buoyed by masks and accessories for sleep apnea, but CEO Lewis Gradon warned that the company faces tougher comps in the second half of its 2024 fiscal year.
The company reported revenue of $314.4 million for the Homecare Product group for the first half of FY24, a 26% increase from the prior comparable period.
“Evora Full was introduced in the U.S. (in...
F&P highlights mask performance in new guidance
September 12, 2023HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare expects operating revenue for the first half of the 2024 financial year, which ends Sept. 30, 2023, to be about $790 million, a 14% increase compared to the same period the previous year.
The company expects net profit after tax to be between $95 million and $105 million.
“For the first four months of the 2024 financial year, revenue from OSA masks was stronger, and revenue from hospital hardware was marginally...
In brief: RemSleep milestone, Medtrade ‘surge’
September 6, 2023HME News Staff
TAMPA, Fla. – RemSleep has successfully passed testing protocol for 510K clearance of its DeltaWave CPAP mask, including cytotoxity and MLA tests, which were the subject of past issues requiring retesting. The company now expects submit for 510k clearance with the U.S. Food and Drug Administration before the end of September. "This is a substantial and critical milestone for RemSleep and the DeltaWave mask,” said CEO Tom Wood. “It has taken significantly longer to get to this point...
RemSleep crosses milestone
September 5, 2023HME News Staff
TAMPA, Fla. – RemSleep has successfully passed testing protocol for 510K clearance of its DeltaWave CPAP mask, including cytotoxity and MLA tests, which were the subject of past issues requiring retesting. The company now expects submit for 510k clearance with the U.S. Food and Drug Administration before the end of September. "This is a substantial and critical milestone for RemSleep and the DeltaWave mask,” said CEO Tom Wood. “It has taken significantly longer to get to this point...
F&P sticks with mask-first model
May 31, 2023Liz Beaulieu, Editor
AUCKLAND, New Zealand – Fisher & Paykel Healthcare’s mask revenue was up 28%, or 24% in constant currency, in the second half of the company’s 2023 fiscal year compared to the same period last year, thanks to a boost from its well-received Evora Full mask.
F&P launched Evora in May 2022 in the United States.
“It’s been a significant contributor to mask revenue,” said Lewis Gradon, CEO, during a call to discuss the company’s latest financial...
How do oronasal masks affect upper airway anatomy and collapsibility?
April 10, 2023HME News Staff
YARMOUTH, Maine – Oronasal masks are associated with a more collapsible airway than nasal masks, which likely contributes to the need for a higher therapeutic pressure, according to a new study published in the journal Chest. CPAP therapy delivered via an oronasal mask is associated with lower adherence, higher residual AHI and increased pressure compared to nasal masks; however, the mechanisms underlying the increased pressure requirements are not well understood. Researchers found oronasal...
Philips issues voluntary recall of certain masks
September 7, 2022HME News Staff
PITTSBURGH – Philips Respironics is alerting users of certain CPAP or Bi-Level PAP therapy masks with magnetic headgear clips or straps that these devices should not be used by or near patients and their household members, caregivers and bed partners who have metallic implanted devices or metallic objects (such as metallic splinters) in the body.
The magnetic headgear clips are used to attach the headgear straps to the masks, a commonly used method in sleep therapy devices.
This...